Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
COLUMN: Action on 340B Contract Pharmacies Turns to the States
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.